Methylphenidate LA, also known as Concerta, is a central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) [1]. It is an extended-release formulation of methylphenidate, designed to release the medication gradually over a 12-hour period [2]. This prolonged release is achieved through a unique osmotic tablet system that controls the rate of drug delivery [3].
How does Concerta (Methylphenidate LA) work?
Concerta's extended-release mechanism relies on an osmotic pump system. The tablet has a semipermeable membrane and one or more laser-drilled holes. As the tablet moves through the gastrointestinal tract, water enters through the membrane, increasing internal pressure. This pressure then pushes the medication out through the hole at a controlled rate [3]. This allows for a once-daily dosage, improving adherence and providing consistent symptom control for individuals with ADHD [2].
When does the patent for Concerta expire?
The patent situation for Concerta is complex, involving multiple patents with varying expiration dates and ongoing litigation. DrugPatentWatch.com tracks these expirations and challenges [4]. Historically, the primary patent for the OROS (Osmotic Controlled Release Oral Delivery System) technology used in Concerta expired in 2011 [5]. However, additional patents related to specific formulations, manufacturing processes, or methods of use may have later expiration dates or have been subject to legal challenges [4].
What generic versions of Methylphenidate LA are available?
Following the expiration of key patents, generic versions of methylphenidate extended-release tablets have become available. These generics are bioequivalent to Concerta, meaning they deliver the same amount of active ingredient into the bloodstream over the same period [6]. The availability of generics typically leads to lower pricing for the medication [4].
Why are companies challenging the patents for Concerta?
Pharmaceutical companies often challenge drug patents to accelerate the introduction of generic versions. If a challenger can prove a patent is invalid or that their product does not infringe on a valid patent, they can bring their generic to market sooner. This is a common strategy in the pharmaceutical industry to gain market share once primary market exclusivity ends [4].
What are the risks and side effects associated with Methylphenidate LA?
Like all stimulant medications, Concerta can have side effects. Common side effects include decreased appetite, insomnia, headache, stomach pain, and increased blood pressure [1]. More serious side effects can include cardiovascular issues, psychiatric problems such as psychosis or mania, and growth suppression in children [7]. Patients and healthcare providers carefully weigh these risks against the benefits of ADHD symptom management [1].